CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, Björn Papke, Jeff A. Klomp, Andrew M. Waters, Clint A. Stalnecker, Jonathan M. DeLiberty, Kristina Drizyte-Miller, Runying Yang, J. Nathaniel Diehl, Hongwei H. Yin, Mariaelena Pierobon, Elisa Baldelli, Meagan B. Ryan, Siqi Li, Jackson Peterson, Amber R. Smith, James T. Neal, Aaron K. McCormickCalvin J. Kuo, Christopher M. Counter, Emanuel F. Petricoin, Adrienne D. Cox, Kirsten L. Bryant, Channing J. Der*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry